Influence of Terminal Functionality on the Crystal Packing Behaviour and Cytotoxicity of Aromatic Oligoamides.
Influence of Terminal Functionality on the Crystal Packing Behaviour and Cytotoxicity of Aromatic Oligoamides.
复制标题
DOI:
10.3389/fchem.2021.709161
复制
发表时间:
2021
影响因子:
5.5
通讯作者:
Pike SJ
中科院分区:
文献类型:
--
作者:
Delfosse P;Seaton CC;Male L;Lord RM;Pike SJ
The synthesis and characterization of three aromatic oligoamides, constructed from the same pyridyl carboxamide core but incorporating distinct end groups of acetyl (Ac) 1, tert-butyloxycarbonyl (Boc) 2 and amine 3 is reported. Single crystal X-ray diffraction analysis of 1–3 and a dimethylsulfoxide (DMSO) solvate of 2 (2-DMSO), has identified the presence of a range of intra- and intermolecular interactions including N-H⋯N, N-H⋯O=C and N-H⋯O=S(CH3)2 hydrogen-bonding interactions, C-H⋯π interactions and off-set, face-to-face stacking π-π interactions that support the variety of slipped stack, herringbone and cofacial crystal packing arrangements observed in 1–3. Additionally, the cytotoxicity of this series of aromatic oligoamides was assessed against two human ovarian (A2780 and A2780cisR), two human breast (MCF-7 and MDA-MB-231) cancerous cell lines and one non-malignant human epithelial cell line (PNT-2), to investigate the influence of the terminal functionality of these aromatic oligoamides on their biological activity. The chemosensitivity results highlight that modification of the terminal group from Ac to Boc in 1 and 2 leads to a 3-fold increase in antiproliferative activity against the cisplatin-sensitive ovarian carcinoma cell line, A2780. The presence of the amine termini in 3 gave the only member of the series to display activity against the cisplatin-resistance ovarian carcinoma cell line, A2780cisR. Compound 2 is the lead candidate of this series, displaying high selectivity towards A2780 cancer cells when compared to non-malignant PNT-2 cells, with a selectivity index value >4.2. Importantly, this compound is more selective towards A2780 (cf. PNT-2) than the clinical platinum drugs oxaliplatin by > 2.6-fold and carboplatin by > 1.6-fold.
登录
查看更多内容
影响因子:
3.3
作者:
Nishio, Motohiro
通讯作者:
Nishio, Motohiro
影响因子:
4.3
作者:
Annala, Riia;Suhonen, Aku;Nissinen, Maija
通讯作者:
Nissinen, Maija
影响因子:
3.3
作者:
König, B;Papke, U;Rödel, M
通讯作者:
Rödel, M
影响因子:
3.1
作者:
Suhonen, Aku;Kortelainen, Minna;Nissinen, Maija
通讯作者:
Nissinen, Maija
DOI:
10.1002/anie.199404461
发表时间:
1994-03-03
期刊:
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION IN ENGLISH
影响因子:
--
作者:
HAMURO, Y;GEIB, SJ;HAMILTON, AD
通讯作者:
HAMILTON, AD